Chemistry: analytical and immunological testing – Including use of radioactive properties – Dosage determination of high energy radiation
Reexamination Certificate
2011-01-04
2011-01-04
Gabel, Gailene R (Department: 1641)
Chemistry: analytical and immunological testing
Including use of radioactive properties
Dosage determination of high energy radiation,
C436S035000, C436S057000, C436S063000, C436S064000, C436S124000, C424S001110, C424S001130, C424S001170, C424S001330, C424S001370, C424S001850, C424S009200, C424S009370, C424S009400, C424S009450
Reexamination Certificate
active
07863047
ABSTRACT:
New intracorporeal photodynamic medicaments and certain medical uses and methods for use of such photodynamic medicaments for treatment of disease in human or animal tissue are described, wherein a primary active component of such medicaments is a halogenated xanthene or halogenated xanthene derivative. In preferred embodiments, such medicaments are used for treatment of a variety of conditions affecting the skin and related organs, the mouth and digestive tract and related organs, the urinary and reproductive tracts and related organs, the respiratory tract and related organs, the circulatory system and related organs, the head and neck, the endocrine and lymphoreticular systems and related organs, various other tissues, such as connective tissues and various tissue surfaces exposed during surgery, as well as various tissues exhibiting microbial or parasitic infection. In another preferred embodiment, such medicaments are produced in various formulations including liquid, semisolid, solid or aerosol delivery vehicles.
REFERENCES:
patent: 4490543 (1984-12-01), Berquist et al.
patent: 4599227 (1986-07-01), Dees et al.
patent: 4647578 (1987-03-01), Crounse et al.
patent: 4846789 (1989-07-01), Heitz et al.
patent: 4957481 (1990-09-01), Gatenby
patent: 4973848 (1990-11-01), Kolobanov et al.
patent: 5053006 (1991-10-01), Watson
patent: 5128139 (1992-07-01), Brown et al.
patent: 5149801 (1992-09-01), Kahl et al.
patent: 5177073 (1993-01-01), Gulliya et al.
patent: 5284831 (1994-02-01), Kahl et al.
patent: 5573773 (1996-11-01), Kis et al.
patent: 5576013 (1996-11-01), Williams et al.
patent: 5591422 (1997-01-01), Hemmi et al.
patent: 5654423 (1997-08-01), Kahl et al.
patent: 5827186 (1998-10-01), Chen
patent: 5829448 (1998-11-01), Fisher et al.
patent: 5832931 (1998-11-01), Wachter et al.
patent: 5998597 (1999-12-01), Fisher et al.
patent: 6042603 (2000-03-01), Fisher et al.
patent: 6331286 (2001-12-01), Dees et al.
patent: 7353829 (2008-04-01), Wachter et al.
patent: 7390668 (2008-06-01), Dees et al.
patent: 7402299 (2008-07-01), Dees et al.
patent: 2007/0010575 (2007-01-01), Dees et al.
patent: 2008/0118578 (2008-05-01), Dees et al.
patent: 0 097 012 (1983-12-01), None
patent: 0 175 617 (1986-03-01), None
patent: 6-128128 (1994-05-01), None
patent: WO 96/07431 (1996-03-01), None
patent: WO 97/03697 (1997-02-01), None
patent: WO 97/03697 (1997-02-01), None
patent: WO 97/26920 (1997-07-01), None
patent: WO 97/39064 (1997-10-01), None
patent: WO 97/40829 (1997-11-01), None
patent: WO 00/02576 (2000-01-01), None
patent: WO 00/25665 (2000-05-01), None
patent: WO 00/25819 (2000-05-01), None
patent: WO 00/25829 (2000-05-01), None
patent: WO 00/37927 (2000-06-01), None
U.S. Appl. No. 09/382,622, filed Aug. 25, 1999.
U.S. Appl. No. 09/635,276, filed Aug. 9, 2000.
U.S. Appl. No. 09/799,785, filed Mar. 6, 2001.
U.S. Appl. No. 09/817,448, filed Mar. 26, 2001.
U.S. Appl. No. 09/900,355, filed Jul. 6, 2001.
U.S. Appl. No. 10/331,854, filed Dec. 30, 2002.
U.S. Appl. No. 11/124,654, filed May 9, 2005.
Neckers, D.C., “Rose Bengal,” Journal of Photochemistry and Photobiology, A: Chemistry, vol. 47, 1989, pp. 1-29.
Serafini, A.N. et al, “Iodine-123-Rose Bengal: An Improved Hepatobiliary Imaging Agent,” Journal of Nuclear Medicine, vol. 16, No. 7, pp. 629-632, 1990.
Young, S.W. et al, “Gadolinium(III) Texaphyrin: A Tumor Selective Radiation Sensitizer that is Detectable by MRI,” Proc. Natl. Acad. Sci. USA, vol. 93, Jun. 1996, pp. 6610-6615.
Bernard, E.J. et al, “Re-Evaluating Gadolinium(III) Texaphyrin as a Radiosensitizing Agent,” Cancer Research, vol. 60, Jan. 1, 2000, pp. 86-91.
Fisher, A.M.R. et al, “Clinical and Preclinical Photodynamic Therapy,” Lasers in Surgery and Medicine, vol. 17, 1995, pp. 2-31.
Niemz, M.H.,Laser-Tissue Interactions, Springer-Verlag, Berlin, Heidelberg, 1996, pp. 45-147.
International Search Report re application No. PCT/US01/08924, dated Jun. 22, 2001.
European Search Report re application No. EP 01920579.8, dated Apr. 21, 2004.
Johansson, S., “Analysis and Purification of Rose Bengal Sodium for Use as Reference Substance and in Pharmaceutical Preparations,” Svensk Farmaceutisk Tidskrift, vol. 77, No. 13, 1973, pp. 641-647 (abstract).
Windholz, M. et al, editors,The Merck Index, 10thedition, Rose Bengal, entry No. 8131, 1983, p. 1191, 1983.
Shi, J. et al, “Xanthenes: Fluorone Derivatives,” Journal of Organic Chemistry, vol. 57, No. 16, Jul. 31, 1992, pp. 4418-4421.
Diwu, Z. et al, “Phototherapeutic Potential of Alternative Photosensitizers to Porphyrins,” Pharmac. Ther., vol. 63, 1994, pp. 1-35.
Heitz, J.R. et al, “Photodegradation of Halogenated Xanthane Dyes,” Mississippi Agriculture and Forestry Experiment Station (MAFES), Publication No. 8532, pp. 35-48, 1989.
Kalka, K. et al, “Photodynamic Therapy in Dermatology,” J. Am. Acad. Derm., vol. 42, 2000, pp. 389-413.
Von Tappeiner, H. et al, Therapeutische Versuche mit Fluoreszierenden Stoffen (Therapeutic Experiments with Fluorescent Substances), Munch. Med. Wochenschr., vol. 47, 1903, pp. 2042-2044.
Dees H. Craig
Fisher Walter G.
Scott Timothy C.
Smolik John
Wachter Eric A.
Gabel Gailene R
Husch Blackwell LLP Welsh & Katz
Provectus Pharmatech, Inc.
LandOfFree
Intracorporeal medicaments for photodynamic treatment of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Intracorporeal medicaments for photodynamic treatment of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Intracorporeal medicaments for photodynamic treatment of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2620099